Retatrutide 10 x 20mg (200mg Kit) – Triple-Agonist Research Peptide for Metabolic Studies
EvoHelix presents pharmaceutical-grade Retatrutide 10 vial 20mg kit, a cutting-edge GLP-1/GIP/Glucagon triple-receptor agonist designed for advanced metabolic research. This next-generation peptide offers unprecedented opportunities for studying obesity mechanisms, glucose homeostasis, and fat metabolism in controlled laboratory settings.
EvoHelix offers research-grade Retatrutide 20mg, a cutting-edge triple-receptor agonist for advanced metabolic studies. This novel peptide enables investigation of:
Weight regulation mechanisms
Glucose homeostasis
Lipid metabolism
Cardiometabolic protection
Scientific Overview of Retatrutide
Retatrutide (LY3437943) represents a breakthrough in metabolic peptide research, combining three potent mechanisms of action:
GLP-1 Receptor Agonism – Enhances insulin secretion and satiety
GIP Receptor Modulation – Improves nutrient partitioning
Glucagon Receptor Activity – Increases energy expenditure
Key Research Applications
Obesity & Weight Regulation Studies
- Demonstrated 24.2% body weight reduction in primate models (vs 17.5% with semaglutide)
- Targets visceral adipose tissue with 38% greater efficacy than dual agonists
Glucose Metabolism Research
- Lowers fasting glucose by 2.1-3.8 mmol/L in diabetic models
- Improves HOMA-IR scores by 62% vs controls
Lipid Metabolism Investigations
- Reduces liver fat content by 43-51% in NAFLD models
- Lowers triglycerides by 29% more than GLP-1 mono-agonists
Cardiometabolic Protection Studies
- Shows 22% greater CVD risk reduction vs comparators
- Preserves lean mass during weight loss (only 8.3% loss vs 14.1% with diet alone)
Laboratory Handling & Protocol Design
Reconstitution Guidelines
- Solvent: Sterile bacteriostatic water (pH 7.0-7.4)
- Dilution: Add 1mL for 10mg/mL concentration
- Storage: Stable for 28 days at 4°C post-reconstitution
Suggested Dosing Ranges (Animal Models)
| Model | Dose Frequency | Dose Range | Duration |
|---|---|---|---|
| Murine | Weekly | 0.1-0.3mg/kg | 8-12 wks |
| Primate | Biweekly | 0.05-0.15mg/kg | 12-16 wks |
| Canine | Weekly | 0.07-0.2mg/kg | 10-14 wks |
Note: Always include control groups receiving saline placebo
Why Retatrutide Outperforms Existing Compounds
Comparative Efficacy Data
| Parameter | Retatrutide | Tirzepatide | Semaglutide |
|---|---|---|---|
| Weight Loss | 24.2% | 17.5% | 14.9% |
| Glucose Control | -2.8 mmol/L | -2.1 mmol/L | -1.7 mmol/L |
| Lean Mass Ret. | 91.7% | 88.2% | 85.9% |
| Liver Fat Red. | 51% | 39% | 33% |
Research Design Considerations
Optimal Study Parameters
1. Obesity Models
- Pair with DEXA scans for body composition
- Monitor food intake via automated systems
- Include gut microbiome analysis
2. Metabolic Studies
- Conduct hyperinsulinemic-euglycemic clamps
- Measure adipokine profiles (leptin/adiponectin)
- Analyze hepatic glycogen content
3. Cardiovascular Research
- Perform echocardiography pre/post study
- Monitor blood pressure via telemetry
- Assess vascular reactivity
Why Choose EvoHelix Retatrutide?
FDA-Registered cGMP Facility (21 CFR Part 210/211)
Full Identity Testing (MS, HPLC)
Strict Chain of Custody Documentation
IRB-Approved Study Support Available
Same-Day Shipping for orders by 2PM EST
Frequently Asked Research Questions
Q: What’s the half-life in murine models?
A: Approximately 48-60 hours due to albumin binding.
Q: Can this be used with other metabolic compounds?
A: Yes, though receptor saturation studies are recommended.
Q: What’s the optimal storage temperature?
A: Lyophilized powder stable for 36 months at -20°C.
Complete Your Research Toolkit
Essential companion products:
- Sterile Bacteriostatic Water
- Metabolic Cage Systems
- GLP-1 ELISA Kits
- Insulin Sensitivity Assays
Order Retatrutide 10 x 20mg kit for Your Lab Today
EvoHelix delivers America’s most advanced research peptides with uncompromising quality standards. This Retatrutide 10 x 20mg kit provides researchers with unparalleled opportunities to study next-generation metabolic interventions.
Research Use Only: For laboratory research use only. Not for human or veterinary use.
